Radboud University Medical Center
Clinical trials sponsored by Radboud University Medical Center, explained in plain language.
-
Could a higher dose of rifampicin beat TB faster?
Disease control Recruiting nowThis study tests whether a higher dose of the antibiotic rifampicin (1800 mg daily) is safe and works better than the standard dose for adults with pulmonary tuberculosis. About 164 participants will be randomly assigned to either the optimized or standard dose. Researchers will …
Phase: PHASE3 • Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Heart drug may speed ventilator weaning in ICU
Disease control Recruiting nowThis study tests whether levosimendan, a drug that strengthens heart and breathing muscles, can help critically ill patients get off a ventilator faster. About 250 adults who have been on a breathing machine for over 48 hours and failed a breathing test will receive either the dr…
Phase: PHASE4 • Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New drug aims to silence harmful antibodies in kidney disease
Disease control Recruiting nowThis study tests a drug called obinutuzumab in 20 adults with a high-risk form of membranous nephropathy, a kidney disease caused by antibodies attacking the kidneys. The goal is to see how quickly the drug lowers those harmful antibodies and whether it leads to remission. Partic…
Phase: PHASE2, PHASE3 • Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Smarter radiation for head & neck cancer: Biopsy-Guided treatment may spare patients from dry mouth
Disease control Recruiting nowThis phase 3 trial tests whether using a sentinel lymph node biopsy to guide radiation can safely reduce the amount of neck radiation in people with certain head and neck cancers. The goal is to lower long-term side effects like severe dry mouth while still controlling the cancer…
Phase: PHASE3 • Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New vaccine trains immune system to fight ovarian cancer
Disease control Recruiting nowThis early-phase trial tests a personalized vaccine made from a patient's own immune cells and tumor material in 10 women with advanced ovarian cancer. The goal is to see if the vaccine can safely boost the immune system to recognize and attack cancer cells after chemotherapy. Th…
Phase: PHASE1, PHASE2 • Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Protein and exercise after bariatric surgery: a Muscle-Saving combo?
Disease control Recruiting nowThis study tests whether taking daily protein supplements and doing resistance exercises (like lifting weights) can prevent too much muscle loss after bariatric surgery. About 400 patients will be randomly assigned to either standard care or standard care plus the protein and exe…
Phase: NA • Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Jun 26, 2026 13:59 UTC
-
New MRI method could speed up bladder cancer diagnosis
Diagnosis Recruiting nowThis study compares a new diagnostic approach—using an MRI plus a same-day biopsy—against the standard procedure (TURBT) for diagnosing muscle-invasive bladder cancer. Researchers will enroll 360 adults suspected of having this aggressive cancer. The goal is to see if the new met…
Phase: NA • Sponsor: Radboud University Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 08:09 UTC
-
New imaging trick could sharpen cancer scans
Diagnosis Recruiting nowThis early-phase study tests a new imaging agent (TGW211) in 19 adults with HER2-positive solid tumors. The goal is to see if a special 'trigger' can help clear the imaging tracer from healthy tissues faster, making tumor scans clearer. The study focuses on safety and image quali…
Phase: EARLY_PHASE1 • Sponsor: Radboud University Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 07:57 UTC
-
Can a common ADHD drug help Parkinson's patients stop freezing in their tracks?
Symptom relief Recruiting nowThis study tests whether atomoxetine, a medication that affects noradrenaline, can reduce freezing of gait in people with Parkinson's disease. About 60 participants will take either atomoxetine or a placebo and perform walking tests, MRI scans, and questionnaires. The goal is to …
Phase: PHASE3 • Sponsor: Radboud University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
App-Based lifestyle coaching tested as depression treatment in GP clinics
Symptom relief Recruiting nowThis study tests whether a smartphone app that provides personalized lifestyle advice can help reduce depression symptoms in adults visiting their general practitioner. 216 participants will either use the app alongside their usual care or receive usual care alone. The app helps …
Phase: NA • Sponsor: Radboud University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
New risk model could spare endometrial cancer patients unnecessary surgery
Knowledge-focused Recruiting nowThis study is testing a computer model called ENDORISK that helps doctors predict whether endometrial cancer has spread to lymph nodes. About 735 patients with early-stage endometrial cancer will use the model to guide decisions about lymph node surgery. The goal is to see if the…
Phase: NA • Sponsor: Radboud University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Could Plant-Based hospital drinks be as good as Milk-Based ones? a new study aims to find out
Knowledge-focused Recruiting nowThis pilot study tests whether it's possible to run a larger trial comparing plant-based and animal-based oral nutritional supplements (ONS) in hospital patients at risk of malnutrition. Sixty patients from two Dutch hospitals will be randomly assigned to receive either a soy-bas…
Phase: NA • Sponsor: Radboud University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Blood test may spot returning prostate cancer earlier
Knowledge-focused Recruiting nowThis study looks at whether a special blood test can find tiny bits of tumor DNA left after prostate cancer surgery. The goal is to see if this test can better predict if the cancer will come back early in high-risk patients. About 50 men with high-risk prostate cancer will give …
Sponsor: Radboud University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
AI and Super-Scope join forces to predict heart attacks
Knowledge-focused Recruiting nowThis study looks at 1000 people with heart artery disease who already need a special camera (OCT) inside their arteries during a routine procedure. Researchers will use those detailed images and artificial intelligence to find patterns that might predict future heart problems, li…
Sponsor: Radboud University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Sepsis study aims to unlock immune secrets for better treatment
Knowledge-focused Recruiting nowThis study looks at how the immune system reacts during and after sepsis in 400 intensive care patients. Researchers will analyze blood samples to identify different immune response types, called immunotypes. The goal is to understand which immune patterns lead to better or worse…
Sponsor: Radboud University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Ventilator study aims to Fine-Tune breathing support for ICU patients
Knowledge-focused Recruiting nowThis study looks at how changing the pressure in a breathing machine (ventilator) affects the effort and drive to breathe in 20 ICU patients with severe lung failure. Researchers will test six different pressure levels and measure breathing muscles, lung activity, and oxygen leve…
Phase: NA • Sponsor: Radboud University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC